On October 13, 2014 the Metastatic Breast Cancer Alliance revealed the results of an analysis that identified 169 new target therapies under development for the treatment of metastatic…
Neil K. Warma, President & CEO, Opexa Therapeutics, delves into Opexa’s Phase 2B ABILI-T Clinical Trial for secondary progressive multiple sclerosis (MS) that expects to yield top-line results in 2016. Previous studies showed that with…
Kristen Kulasa, MD, VA San Diego Healthcare System discusses point of care, how often patients should monitor their blood sugar, and how to determine outpatient regimens. Right now…
Kristen Kulasa, MD, VA San Diego Healthcare System talks about the current recommendations for managing patients with diabetes during their time in the hospital. Patients who are admitted…
Kristen Kulasa, MD, VA San Diego Healthcare System, continues with Steven Edelman, MD and discusses the unmet needs in inpatient care. The continuous glucose monitor (CGM) is a new technology…
Jane Jeffrie Seley, DNP, MPH, New York-Presbyterian/Weill Cornell Medical Center, discusses the transition from inpatient to outpatient care in patients with diabetes. When patients return home, diabetes experts…
Charlotte Collins, J.D., Senior Vice President, Policy and Programs, Asthma and Allergy Foundation of America talks about the risk of allergy, asthma, and anaphylaxis at school. Many children will have…
Jane Jeffrie Seley, DNP, MPH, New York-Presbyterian/Weill Cornell Medical Center talks about follow-up and how to prevent readmissions to the ER. Allowing patients to go in incremental steps with…
Martin Lee, director, Project CBD, talks about the JAMA article that highlights the 25 percent decrease in overdose deaths from opiates in states where medical marijuana is legal. According…
Martin Lee, director, Project CBD talks about the medical benefits of cannabidiol (CBD). CBD is the non-psychoactive compound in cannabis, and can serve as an effective therapy for cardiovascular disease,…
Fed up with you current job? Visit The Doctor’s Channel Career Center, where you’ll find the latest job opportunities from pharmaceutical companies both in the US and worldwide.…
According to Reuters, DVB Technologies, developer of the “peanut allergy patch,” will begin marketing in the US today for additional funding to advance research. Viaskin Peanut, the new patch…
